Skip to main content

Security Directory

Explore comprehensive security analyses from websites around the world. Filter by industry, location, risk level, and more.

Live Guard activity

Security teams are checking their sites with Guard right now

Run your domain before the queue fills up

0
Websites
0
Industries
0
Countries
0
Avg Score
Page 102 of 127|Showing 5051-5100 of 6317
chiesi.pl favicon

Chiesi Poland

chiesi.pl

0
HealthcarePolandmediumMEDIUM

Chiesi Poland operates as a pharmaceutical company specializing in therapeutic areas such as respiratory health, neonatology, transplantology, and pediatrics. The company is part of the international Chiesi Group and demonstrates a commitment to corporate social responsibility, sustainability, and ethical business practices, evidenced by its B Corp certification. The website serves healthcare professionals, patients, and partners in Poland, providing product information, corporate news, and resources. Technically, the website employs a range of JavaScript libraries including jQuery, bxSlider, and Colorbox, alongside Google Maps API and OneTrust for cookie consent management. Accessibility is enhanced through the integration of AccessiWay. The site is mobile optimized and presents a professional design with clear navigation, although SEO metadata and structured data are minimal. From a security perspective, the site enforces HTTPS and uses a cookie consent mechanism, but lacks visible security headers and does not publish a security or incident response policy. No vulnerabilities or exposed sensitive data were detected in the HTML content. The absence of WHOIS data limits domain trust verification, but the professional content and corporate branding support legitimacy. Overall, the website is well-constructed and compliant with privacy regulations, but could improve transparency around security policies and domain registration details to enhance trust and security posture.

80
73
2
85
67
75
100
pharmaceuticalhealthcarecorporatebcorpprivacy+2 more
jQuerybxSliderColorboxGoogle Maps API+2

Partner Domains:

www.chiesi.com
parent
totylkoastma.pl
partner

+1 more partners

2025-07-08T23:56:23.559Z
amgen.pl favicon

Amgen Polska Sp. z o.o.

amgen.pl

0
HealthcarePolandlargeMEDIUM

Amgen Polska Sp. z o.o. operates as a subsidiary of the global biotechnology leader Amgen Inc., focusing on innovative human therapeutics within the healthcare sector. The website serves healthcare professionals, patients, and partners by providing comprehensive information about products, corporate affairs, and patient support programs. The company holds a strong market position in Poland, supported by its global reputation and local presence. The business model centers on biopharmaceutical development and patient engagement, reflecting a mature and established enterprise founded in 1980. Technically, the website employs modern web technologies including JavaScript frameworks, Bootstrap for responsive design, and Cookiebot for consent management, indicating a good level of digital maturity. The site is mobile-optimized and incorporates SEO best practices, although some accessibility features could be enhanced. Hosting details are not explicit, but the infrastructure supports moderate performance and reliable user experience. From a security perspective, the site enforces HTTPS with a solid SSL configuration and includes a Content Security Policy header. Cookie consent mechanisms comply with GDPR, and no critical vulnerabilities or exposed sensitive data were detected. However, additional security headers and a formal security policy could further strengthen the posture. The WHOIS data confirms the legitimacy and consistency of the domain registration with the corporate identity. Overall, the website presents a low-risk profile with strong business credibility and compliance adherence. Strategic recommendations include enhancing security headers, publishing incident response contacts, and improving accessibility to elevate the user experience and security maturity further.

80
100
2
40
74
75
100
healthcarebiotechnologypharmaceuticalcorporategdpr+1 more
JavaScriptjQueryBootstrapVideoJS+2
2025-07-08T23:55:48.500Z
alector.com favicon

Alector Therapeutics

alector.com

0
HealthcareUnited StatesmediumLOW

Alector Therapeutics is a biopharmaceutical company specializing in developing therapies for neurodegenerative diseases. Founded in 2008, the company positions itself as an innovative player in the healthcare sector, focusing on advancing treatments that address critical unmet needs in neurodegeneration. Their website targets patients, investors, and the scientific community, providing detailed information about their scientific approach, pipeline, and patient resources. The company maintains a professional online presence with comprehensive privacy and cookie policies, reflecting strong compliance with GDPR and data protection standards. Technically, the website is built on WordPress and leverages modern web technologies including jQuery, Bootstrap, and Flickity for UI components, alongside Google Tag Manager for analytics and OneTrust for cookie consent management. The site is mobile-optimized and demonstrates good SEO and accessibility practices, although some accessibility features could be enhanced. Hosting and DNS are managed via DomainControl, with no DNSSEC enabled, which is a recommended improvement. From a security perspective, the site enforces HTTPS and uses cookie consent mechanisms, but lacks some advanced security headers such as Content-Security-Policy and X-Content-Type-Options. No vulnerabilities or exposed sensitive data were detected in the HTML content. The WHOIS data confirms domain legitimacy with a long registration period and appropriate domain status flags. Overall, the security posture is solid but could benefit from additional hardening. The overall risk assessment is low, with no signs of malicious activity or suspicious content. Strategic recommendations include enabling DNSSEC, implementing additional security headers, and publishing a vulnerability disclosure policy to enhance transparency and trust. The website's design, content quality, and compliance measures position Alector as a credible and trustworthy healthcare company online.

70
88
2
80
95
85
100
biopharmaceuticalneurodegenerativehealthcareprivacygdpr+3 more
jQueryBootstrapFlickityGoogle Tag Manager+2

Partner Domains:

investors.alector.com
subsidiary
2025-07-08T23:53:12.929Z
mozart-tx.com favicon

Mozart Therapeutics

mozart-tx.com

0
HealthcareN/asmallMEDIUM

Mozart Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of novel CD8 Treg modulators aimed at treating autoimmune and inflammatory diseases. Their website presents a professional and scientifically focused image, highlighting their pipeline and scientific approach. The company targets healthcare professionals, investors, and patients interested in innovative autoimmune therapies. The business model centers on advancing proprietary biologics to restore immune homeostasis. Technically, the website employs a simple tech stack including jQuery 1.9.0 and Google Analytics with IP anonymization. The site is well-structured, mobile-optimized, and accessible, though it lacks modern frameworks or CMS identification. Performance is moderate, and SEO practices are adequate. However, the use of an outdated JavaScript library and absence of security headers suggest areas for technical improvement. From a security perspective, the site lacks visible security headers and formal privacy or cookie policies, which impacts privacy compliance negatively. No contact information or incident response channels are provided, limiting transparency and trust. The WHOIS data is notably absent, raising concerns about domain registration legitimacy despite the active and professional website presence. This discrepancy reduces overall trustworthiness. Overall, the website is functional and professional but requires improvements in privacy compliance, security posture, and domain registration transparency to enhance trust and security. Strategic recommendations include implementing security headers, publishing privacy and cookie policies with consent mechanisms, providing clear contact and incident response information, updating technical libraries, and clarifying domain registration details.

50
35
2
70
62
70
100
biopharmaceuticalautoimmuneclinical-stagecd8tregimmunesystem+1 more
jQuery 1.9.0Google Analytics (gtag.js)
2025-07-08T23:52:37.605Z
induprolabs.com favicon

InduPro, Inc.

induprolabs.com

0
HealthcareUnited StatesmediumMEDIUM

InduPro, Inc. is a biotechnology company specializing in proximity-based therapeutics, focusing on manipulating protein interactions on cell surfaces to develop innovative treatments for diseases. The company targets pharmaceutical and biotech sectors, leveraging proprietary platforms to facilitate new biology and drug discovery. Their website presents a professional image with clear scientific and team information, positioning them as an innovative player in the healthcare industry. Technically, the website is built on WordPress with modern plugins and libraries such as Yoast SEO, FullPage.js, and D3.js, indicating a moderate to good level of digital maturity. The site is mobile-optimized and SEO-friendly, though some accessibility features could be improved. Security-wise, the site uses HTTPS and modern JavaScript libraries but lacks visible security headers and formal privacy or cookie policies, which are areas for improvement. The security posture is generally good with no visible vulnerabilities or exposed sensitive data, but the absence of WHOIS data for the domain raises concerns about domain registration legitimacy. Contact information is clearly provided, enhancing business credibility. Overall, the site is trustworthy and professional but would benefit from enhanced privacy compliance and domain registration transparency.

15
35
2
85
57
85
100
biotechnologyhealthcareproximitytherapeuticsdrugdiscoveryscience+1 more
WordPressYoast SEO pluginjQueryFullPage.js+4
2025-07-08T23:52:27.588Z
axonis.us favicon

Axonis Therapeutics, Inc.

axonis.us

0
HealthcareUnited StatesmediumMEDIUM

Axonis Therapeutics, Inc. is a Boston-based biotechnology company specializing in neuro-focused drug development targeting KCC2, a key protein involved in neuronal inhibition. The company leverages proprietary technology spun out from leading academic institutions and has secured significant Series A funding to advance its first-in-class oral KCC2 potentiator drug, AXN-027, aimed at treating epilepsy, pain, and other CNS disorders. The website reflects a professional and focused business presence with clear scientific and investment messaging. Technically, the website is built on WordPress using Elementor and Astra theme, with modern web technologies and SEO optimizations in place. The site is mobile-optimized and performs moderately well, though some accessibility features could be improved. Security posture is adequate with HTTPS enforced and domain protections, but lacks advanced security headers and DNSSEC. No direct contact emails or phone numbers are published; contact is via a form. Privacy and cookie policies are minimal, with only an FCOI policy found. No incident response or vulnerability disclosure information is provided, indicating room for improvement in transparency and compliance. Overall, the website presents a credible and professional biotech company with solid business and technical foundations but could enhance security and privacy compliance to strengthen trust and regulatory adherence.

15
35
2
85
52
75
100
biotechnologyneurologypharmaceuticalskcc2drugdevelopment+2 more
WordPressElementorYoast SEOjQuery+2
2025-07-08T23:52:17.571Z
A

ATB Therapeutics

atbtherapeutics.com

0
HealthcareBelgiumsmallMEDIUM

ATB Therapeutics is a pioneering biotechnology company specializing in novel antibody therapies targeting oncology and auto-immune diseases. Their innovative atbody format and plant-based manufacturing technology position them as an emerging player in the biotech sector, focusing on unmet clinical needs. The company operates primarily in Belgium and has a small but focused organizational size, with a domain age consistent with their founding year of 2017. The website reflects a professional and consistent brand image, targeting healthcare professionals, investors, and partners. Technically, the website is built on modern web technologies including React, uses slick carousel for UI elements, and integrates Google Analytics for user tracking. Hosting is provided by One.com A/S, and the site is mobile-optimized with good performance. However, there is room for improvement in accessibility and SEO optimization. From a security perspective, the site uses HTTPS with good SSL configuration but lacks important security headers and published security policies. No cookie consent mechanism is present, which impacts GDPR compliance. No incident response or vulnerability disclosure information is available, indicating a potential gap in security transparency. Overall, the website is trustworthy and professional but would benefit from enhanced security practices and privacy compliance measures to strengthen its risk posture and user trust.

15
53
2
85
72
60
40
biotechnologyantibodytherapycancerautoimmunediseasehealthcare+2 more
ReactSlick CarouselAnimate.cssGoogle Analytics
2025-07-08T23:52:12.562Z
anavotx.com favicon

Anavo Therapeutics

anavotx.com

0
HealthcareUnited StatessmallMEDIUM

Anavo Therapeutics is a pioneering biopharmaceutical company focused on drug discovery targeting phosphatases, a previously undruggable target class. Utilizing their proprietary IGNITE platform, they develop allosteric modulators for therapeutic programs in autoimmune diseases and cancer. The company is supported by reputable international investors and led by an experienced management team with strong scientific advisory backing. The website reflects a professional and consistent brand image with clear business focus and investor transparency. Technically, the website is built on the Squarespace platform with embedded Vimeo videos and uses modern web fonts and scripts. It is mobile optimized and performs moderately well, though accessibility features could be improved. Security posture is strong with HTTPS and HSTS enabled, and a cookie consent mechanism is in place, indicating GDPR awareness. However, the absence of a public WHOIS record, privacy policy, terms of service, and explicit contact information reduces transparency and trust. Overall, the site presents a credible and professional front for a biotech startup but would benefit from enhanced privacy and security disclosures, contact details, and domain registration transparency to improve trust and compliance.

35
95
17
70
62
75
100
biotechphosphatasedrugdiscoveryhealthcarestartup+2 more
Squarespace CMSVimeo video embeddingTypekit fontsJavaScript libraries (Squarespace scripts)

Partner Domains:

merck-ventures.com
partner
bioqubeventures.com
partner

+3 more partners

2025-07-08T23:52:07.536Z
ambagontx.com favicon

Ambagon Therapeutics

ambagontx.com

0
HealthcareN/asmallMEDIUM

Ambagon Therapeutics is a biotechnology company specializing in the development of novel therapeutics that target intrinsically disordered proteins using a proprietary molecular glue platform focused on 14-3-3 proteins. The company positions itself as an innovator in drug discovery, addressing previously undruggable targets with a focus on oncology and other unmet clinical needs. Their website reflects a professional and consistent brand image, targeting industry professionals, investors, and researchers. Technically, the website is built on WordPress with modern plugins such as Yoast SEO and MonsterInsights for analytics. It uses standard web technologies including Bootstrap and jQuery, and is optimized for mobile devices with good accessibility and SEO practices. However, some security best practices such as security headers and explicit cookie consent mechanisms are missing, which could be improved to enhance compliance and security posture. From a security perspective, the site uses HTTPS with good SSL configuration and no visible vulnerabilities or exposed sensitive data. The absence of WHOIS data for the domain introduces some uncertainty regarding domain legitimacy, though the professional presentation and social media presence support trustworthiness. No incident response or security policy information is published, which is a gap for a company in the healthcare sector. Overall, the website presents a credible and professional front for a small biotech company with a specialized focus. Strategic improvements in privacy compliance, security headers, and transparency around security policies would strengthen their security posture and trust. Monitoring domain registration details is recommended to ensure ongoing legitimacy.

15
53
10
85
72
70
100
biotechnologypharmaceuticalmoleculargluedrugdiscovery14-3-3proteins+1 more
WordPressYoast SEO pluginGoogle Analytics (gtag.js)jQuery+5
2025-07-08T23:52:02.524Z
pbs.gov.au favicon

Australian Government Department of Health, Disability and Ageing

pbs.gov.au

0
HealthcareAustralialargeMEDIUM

The Pharmaceutical Benefits Scheme (PBS) website is an official Australian government platform managed by the Department of Health, Disability and Ageing. It provides comprehensive information about medicines subsidised by the government, targeting consumers, carers, health professionals, and the pharmaceutical industry. The site serves as a key resource for PBS news, medicine listings, and regulatory information, positioning itself as a trusted authoritative source in the healthcare sector within Australia. Technically, the website employs a mature but somewhat dated technology stack including jQuery 1.11.1, Bootstrap 2.3.2, and Font Awesome 3.2.1. It integrates Google Analytics and Google Tag Manager for user tracking and analytics. The site is mobile responsive at a basic level and demonstrates good accessibility and SEO practices, though there is room for modernization and enhanced performance optimization. From a security perspective, the site benefits from HTTPS encryption and secure form handling but lacks explicit security headers such as Content Security Policy and HSTS. No vulnerabilities or exposed sensitive data were detected. Privacy compliance is partially met with a clear privacy policy linked to the parent government health site, but the absence of a cookie consent mechanism is a minor gap. WHOIS data is privacy protected but consistent with government domain norms, supporting the legitimacy of the domain. Overall, the PBS website exhibits a high level of professionalism, trustworthiness, and content quality suitable for its essential government healthcare function. Strategic improvements in security headers, cookie consent, and technology modernization would further enhance its security posture and user trust.

75
53
17
85
82
80
100
healthcaregovernmentpharmaceuticalpbsaustralia
jQuery 1.11.1jQuery UI 1.11.0Bootstrap 2.3.2Font Awesome 3.2.1+2
2025-07-08T22:45:49.699Z
medscape.com favicon

Medscape

medscape.com

0
HealthcareUnited StatesenterpriseMEDIUM

Medscape is a leading online platform providing comprehensive medical news, clinical trial updates, drug information, journal articles, and continuing medical education (CME) activities targeted primarily at healthcare professionals and physicians. It operates as a free resource supported by advertising and professional services, positioning itself as a trusted source in the healthcare information market. The website is part of the WebMD Health Corp portfolio, a recognized leader in digital health information. Technically, Medscape employs a modern technology stack including Adobe DTM for tag management, Google DoubleClick for advertising, and OneTrust for privacy compliance, ensuring a robust and scalable infrastructure. The site is well-optimized for performance, mobile responsiveness, and accessibility, delivering an excellent user experience. Security-wise, Medscape enforces HTTPS, implements multiple security headers, and uses cookie consent mechanisms to comply with privacy regulations such as GDPR. No critical vulnerabilities or exposed sensitive data were detected. However, WHOIS data is unavailable or protected, which is common for large brands but limits transparency. Overall, Medscape demonstrates a mature digital presence with strong business credibility and security posture.

55
100
17
60
-
80
100
healthcaremedicalnewsclinicaltrialscmephysicians+1 more
JavaScriptAdobe DTMDoubleClick for Publishers (DFP)OneTrust Cookie Consent+4

Partner Domains:

webmd.com
parent
reference.medscape.com
service

+2 more partners

2025-07-08T22:45:24.658Z
P

Placebo d.o.o

placebo.hr

0
HealthcareCroatiasmallHIGH

Placebo d.o.o is a small Croatian publishing company based in Split, specializing in medical publications and educational content for doctors and patients. The website serves primarily as an informational portal with links to their free mobile application 'LLHZZO' available on iOS and Android platforms. The business targets healthcare professionals and patients, focusing on pharmacology and medical education within the Croatian market. The company maintains a modest online presence with basic content and limited digital marketing or tracking technologies. Technically, the website is built using simple HTML and CSS without modern frameworks or CMS platforms. It lacks advanced SEO, accessibility, and mobile optimization features, though it provides essential contact information and app download links. No analytics or tracking scripts were detected, indicating minimal user data collection. The site does not implement privacy or cookie policies, nor does it display security headers or confirm HTTPS usage, which suggests a low level of security maturity. From a security perspective, the absence of HTTPS and security headers, combined with missing privacy and cookie policies, represents compliance and security gaps. No forms or interactive elements reduce the attack surface, but the site would benefit from implementing standard security best practices and GDPR compliance measures. The WHOIS data aligns well with the website's business claims, showing consistent registration information without privacy protection, appropriate for this type of business. Overall, the website is functional but basic, with room for improvement in security, privacy compliance, and technical modernization. Strategic recommendations include implementing HTTPS, adding privacy and cookie policies, enhancing security headers, and improving mobile and accessibility features to increase trust and compliance.

15
25
17
70
72
80
-
medicalpublishingeducationhealthcarecroatia
HTMLCSS
2025-07-08T21:38:16.383Z
kodeksprzejrzystosci.pl favicon

Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA

kodeksprzejrzystosci.pl

0
HealthcarePolandmediumMEDIUM

The website www.kodeksprzejrzystosci.pl represents the Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA, a Polish association of innovative pharmaceutical companies focused on promoting transparency in cooperation with healthcare professionals and patient organizations. The site provides information about the Transparency Code, publishes annual transparency reports, and serves as a resource for industry standards and ethical cooperation. The organization holds a significant position in the Polish pharmaceutical sector, with affiliations to European bodies such as EFPIA. Technically, the website employs modern web technologies including Google Analytics, Google Tag Manager, and Google reCAPTCHA v3 for security. It uses HTTPS exclusively, ensuring secure communication. The site is well-structured, mobile-optimized, and includes privacy and cookie policies compliant with GDPR. However, no explicit security headers were detected, and WHOIS data for the domain is unavailable, which slightly impacts trustworthiness. From a security perspective, the site demonstrates good practices such as HTTPS enforcement and bot protection via reCAPTCHA. There are no visible vulnerabilities or exposed sensitive data. The absence of WHOIS data is a concern but is mitigated by the professional content and clear organizational affiliations. Overall, the site presents a low risk profile with room for improvement in security headers and incident response transparency. Strategically, the site supports INFARMA's mission to enhance transparency and ethical standards in the pharmaceutical industry in Poland, targeting healthcare professionals, patient groups, and industry stakeholders.

20
10
2
70
65
60
100
pharmaceuticaltransparencyhealthcarecompliancepoland+2 more
Google AnalyticsGoogle Tag ManagerGoogle reCAPTCHA v3jQuery (implied by usage of colorbox and scripts)+1

Partner Domains:

www.infarma.pl
partner
www.efpia.eu
partner

+3 more partners

2025-07-08T21:36:56.198Z
badaniaklinicznewpolsce.pl favicon

Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA

badaniaklinicznewpolsce.pl

0
HealthcarePolandmediumHIGH

INFARMA is a Polish employers' union representing innovative pharmaceutical companies, focusing on advancing medical research, clinical trials, and pharmaceutical innovation. The website serves as an information hub for clinical trials, industry collaboration, and patient education, positioning INFARMA as a leading industry association in Poland. The site is professionally designed, well-structured, and provides comprehensive resources and contact information, including multilingual support and social media presence. Technically, the website employs modern web technologies such as Bootstrap, Google Fonts, Google Analytics, and Google reCAPTCHA, ensuring good performance, mobile responsiveness, and user experience. Security practices include HTTPS enforcement and anti-bot measures, though some security headers could be improved. Privacy and cookie policies are present and GDPR compliant, reflecting a mature approach to data protection. The security posture is solid with no critical vulnerabilities detected, but the absence of WHOIS data reduces transparency and slightly impacts trust. Overall, the site is reliable, professional, and trustworthy, serving its target audience effectively with a strong focus on healthcare and pharmaceutical innovation.

20
10
17
70
62
75
-
pharmaceuticalclinicaltrialshealthcareinnovationpoland+1 more
Google FontsBootstrap CSSjQuery (implied by bootstrap usage)Google Analytics+2

Partner Domains:

www.efpia.eu
partner
www.pracodawcyrp.pl
partner

+3 more partners

2025-07-08T21:36:51.191Z
wewontrest.pl favicon

Związek Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMA

wewontrest.pl

0
HealthcarePolandmediumHIGH

The website 'wewontrest.pl' represents the #ZdrowszyŚwiat initiative by INFARMA, an association of innovative pharmaceutical companies in Poland. It focuses on promoting medical breakthroughs, patient stories, and the pharmaceutical industry's dedication to improving health outcomes. The site targets patients, healthcare professionals, and industry stakeholders with educational and advocacy content. The business model is that of an industry association with a medium-sized presence in the Polish healthcare sector. Technically, the website uses a custom PHP-based CMS with modern web technologies including HTML5, CSS3, JavaScript, Video.js for media, and integrates Google Analytics, Google Tag Manager, Facebook SDK, and Google reCAPTCHA for analytics and security. Hosting is provided by OVH SAS. The site performs moderately well with good mobile optimization and basic accessibility features. From a security perspective, the site enforces HTTPS and uses reCAPTCHA to mitigate bots. However, it lacks visible security headers and does not publish a dedicated security policy or incident response contacts. DNSSEC is not enabled, which is a recommended improvement. No vulnerabilities or exposed sensitive data were detected in the HTML content. Overall, the website is professional, trustworthy, and compliant with GDPR as evidenced by a comprehensive privacy policy and cookie consent mechanism. Contact information is clearly provided, enhancing business credibility. The domain registration data aligns well with the business claims, supporting legitimacy. Strategic recommendations include enabling DNSSEC, adding security headers, and publishing security policies to further strengthen security posture.

20
10
2
70
62
75
-
healthcarepharmaceuticalpatientadvocacymedicineindustryassociation+1 more
HTML5CSS3JavaScriptVideo.js+4

Partner Domains:

www.infarma.pl
partner
www.efpia.eu
partner

+3 more partners

2025-07-08T21:36:41.175Z
acog.org favicon

The American College of Obstetricians and Gynecologists

acog.org

0
HealthcareUnited StateslargeMEDIUM

The American College of Obstetricians and Gynecologists (ACOG) operates a comprehensive and professionally designed website serving as the premier membership organization for obstetrician-gynecologists. The site provides extensive resources including clinical guidelines, educational materials, practice management support, career resources, and advocacy information. The target audience includes healthcare professionals and patients interested in women's health. The organization holds a strong market position as a leading professional body in its sector. Technically, the website leverages modern JavaScript frameworks, integrates advanced search capabilities via Coveo, and employs multiple analytics and marketing tools such as Google Tag Manager, Crazy Egg, and New Relic for performance monitoring. The CMS appears to be Sitecore, indicating a mature digital infrastructure. The site is mobile optimized and accessible, with good SEO practices. From a security perspective, the site enforces HTTPS and uses cookie consent mechanisms, indicating compliance with privacy regulations such as GDPR. While explicit security policies and incident response pages are not publicly found, the use of monitoring tools and privacy policies suggests a reasonable security posture. No critical vulnerabilities or suspicious patterns were detected. Overall, the website presents a low-risk profile with strong business credibility and technical maturity. Recommendations include publishing explicit security headers, adding a vulnerability disclosure policy, and enhancing security contact information to further improve trust and compliance.

35
58
17
75
75
80
100
healthcareprofessionalorganizationobstetricsgynecologyeducation+2 more
JavaScriptGoogle Tag ManagerCrazy EggCoveo Search+3

Partner Domains:

acogcoding.freshdesk.com
partner
www.pathlms.com
partner

+3 more partners

2025-07-08T21:35:40.587Z
msdinsight.fi favicon

MSD Insight Finland

msdinsight.fi

0
HealthcareFinlandenterpriseMEDIUM

MSD Insight Finland operates as a specialized healthcare information portal targeted exclusively at physicians in Finland. The website provides curated content on therapeutic areas such as oncology, vaccines, infections, and chronic cough, supporting healthcare professionals with up-to-date materials and news. The portal is branded under MSD and Merck & Co., indicating a strong corporate backing and market presence in the healthcare sector. The business model focuses on delivering professional, non-promotional healthcare content to a niche audience, reinforcing MSD's position as a trusted healthcare partner in Finland. Technically, the website is built on WordPress with a custom MSD MConnect theme and leverages modern web technologies including Google Tag Manager for analytics and OneTrust for cookie consent management. The site is hosted likely on WordPress VIP, ensuring enterprise-grade hosting and performance. The site demonstrates good mobile optimization, accessibility, and SEO practices, contributing to a positive user experience for its professional audience. From a security perspective, the site enforces HTTPS and implements cookie consent mechanisms aligned with GDPR requirements. While explicit security headers are not visible in the HTML, the overall SSL configuration is excellent, and no exposed sensitive data or vulnerabilities were detected. However, the site lacks publicly available security policies or incident response information, which could be improved to enhance transparency and trust. Overall, MSD Insight Finland presents a professional, secure, and compliant digital presence suitable for its healthcare professional audience. The domain registration and WHOIS data align well with the business identity, supporting the legitimacy of the site. Strategic recommendations include enhancing public security disclosures, verifying security headers, and continuous monitoring of third-party scripts to maintain a strong security posture.

85
48
17
70
52
85
100
healthcarephysicianportalmsdfinlandoncology+5 more
WordPressYoast SEO pluginGoogle Tag ManagerOneTrust cookie consent+2

Partner Domains:

www.msd.fi
partner
www.msdprivacy.com
partner

+1 more partners

2025-07-08T20:27:03.493Z